Technegas named preferred lung imaging agent in new US guideline
Cyclopharm (ASX:CYC) announced a major milestone for its flagship functional lung imaging product, Technegas, following the release of a draft US clinical guideline that recognises it as a preferred ventilation agent.





-4-640x360.png&w=3840&q=75)





